Clinical characteristics of DM1 and DM2 patients and controls at baseline (T1) and follow-up (T2).</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Continuous variables are presented as means ± SD; categorical variables are presented as numbers;...
<p>Characteristics of the MM patients at baseline and association with sFLCR (n = 180).</p
<p>Legend: <sup>§</sup>The values of mean±SD are listed;</p>*<p>Comparison with respective controls;...
Demographic and clinical characteristics of patients with MDD and healthy controls.</p
<p>Clinical characteristics of patients with DM, stratified by autoantibody status.</p
<p>Legend: <sup>§</sup>The values of mean±SD are listed;</p>*<p>Comparison with respective controls;...
<p>Characteristics of DM1 patients according to estimated glomerular filtration rate.</p
Baseline characteristics and outcomes of patients enrolled in DMOC in 2012–2018, by initial DMOC typ...
<p>Clinical characteristics and study outcomes of patients at baseline and follow up.</p
<p>Clinical characteristics of healthy controls and MS subjects in the MRS studies.</p
<p>Characteristics of the patients and healthy controls included in Study 1 and 2.</p
<p>Clinical and biochemical characteristics of controls and hypertriglyceridemic patients.</p
Clinical characteristics of patients with only BC (BC group) and those with BC followed by TC (BC2TC...
Demographic and clinical characteristics of the experimental and control groups at baseline.</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Continuous variables are presented as means ± SD; categorical variables are presented as numbers;...
<p>Characteristics of the MM patients at baseline and association with sFLCR (n = 180).</p
<p>Legend: <sup>§</sup>The values of mean±SD are listed;</p>*<p>Comparison with respective controls;...
Demographic and clinical characteristics of patients with MDD and healthy controls.</p
<p>Clinical characteristics of patients with DM, stratified by autoantibody status.</p
<p>Legend: <sup>§</sup>The values of mean±SD are listed;</p>*<p>Comparison with respective controls;...
<p>Characteristics of DM1 patients according to estimated glomerular filtration rate.</p
Baseline characteristics and outcomes of patients enrolled in DMOC in 2012–2018, by initial DMOC typ...
<p>Clinical characteristics and study outcomes of patients at baseline and follow up.</p
<p>Clinical characteristics of healthy controls and MS subjects in the MRS studies.</p
<p>Characteristics of the patients and healthy controls included in Study 1 and 2.</p
<p>Clinical and biochemical characteristics of controls and hypertriglyceridemic patients.</p
Clinical characteristics of patients with only BC (BC group) and those with BC followed by TC (BC2TC...
Demographic and clinical characteristics of the experimental and control groups at baseline.</p
<p>Characteristics at baseline and at follow-up of the patients included in the study.</p
<p>Continuous variables are presented as means ± SD; categorical variables are presented as numbers;...
<p>Characteristics of the MM patients at baseline and association with sFLCR (n = 180).</p